Trial Profile
A phase I study of a first monoclonal antibody (n-CoDeR)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Aug 2014
Price :
$35
*
At a glance
- Drugs Monoclonal antibodies (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Bayer
- 18 Aug 2014 New trial record
- 07 Jul 2014 The first patient has been enrolled, according to a Bioinvent media release. This event triggered a milestone payment from Bayer.